These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4131322)

  • 1. [Comparison of changes in erythrocyte and resin tests induced by the use of Femigen-forte and Femifen (Polfa) preparations as contraceptives].
    Pisarek-Miedzińska D; Czech W; Firek A
    Ginekol Pol; 1974 Jan; 45(1):57-60. PubMed ID: 4131322
    [No Abstract]   [Full Text] [Related]  

  • 2. Fertility control with 15-8-5.
    Andelman MB
    Fertil Steril; 1970 Apr; 21(4):314-21. PubMed ID: 4101384
    [No Abstract]   [Full Text] [Related]  

  • 3. Sequential mestranol-chlormadinone acetate as an oral contraceptive.
    Tyler ET
    Obstet Gynecol; 1966 Dec; 28(6):787-92. PubMed ID: 4162518
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of the oral contraceptive preparation Femigen on the erythrocyte and resin uptake of 131-I-triiodothyronine].
    Pisarek-Miedzińska D; Czech W; Firek A
    Ginekol Pol; 1972 May; 43(5):595-600. PubMed ID: 4113023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Femigen forte and mite preparations in contraception and gynecologival disorders].
    Sternadel Z; Pietrusiewicz W; Wasilewska B
    Ginekol Pol; 1970 Nov; 41(11):1227-36. PubMed ID: 4098877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on the contraceptive effects of periodic administration of mestranol 0.08mg and chlormadinone acetate 2mg (S-3850 tablets)].
    Kobayashi T; Amemori Y; Watanabe T; Ichikawa T
    Horumon To Rinsho; 1968 May; 16(5):403-9. PubMed ID: 4177677
    [No Abstract]   [Full Text] [Related]  

  • 7. Modified sequential oral contraception employing mestranol with chlormadinone.
    Tyler ET; Matsner EM; Gotlib M
    Obstet Gynecol; 1969 Dec; 34(6):820-4. PubMed ID: 4189147
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experiences with the different dosage of Ovosiston preparations in the framework of marital and sexual counseling. Individual therapy with oral contraceptives].
    Ebeling K; Kühndel K; Rothe K
    Dtsch Gesundheitsw; 1971 Jan; 26(2):61-4. PubMed ID: 4106277
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experiences with different doses of Ovosiston preparations within the scope of marital and sexual counseling. Individual therapy with oral contraceptives].
    Ebeling K; Kühndel K; Rothe K
    Dtsch Gesundheitsw; 1971 Jan; 26(1):31-4. PubMed ID: 4106517
    [No Abstract]   [Full Text] [Related]  

  • 10. Two thousand woman-years' experience with a sequential contraceptive. A more effective method of taking a sequential contraceptive.
    Karrer MC; Smith ER
    Am J Obstet Gynecol; 1968 Dec; 102(7):1029-34. PubMed ID: 4177693
    [No Abstract]   [Full Text] [Related]  

  • 11. Our experience with sequential estrogen-progestin treatments to inhibit ovulation.
    Cittadini E; Quartararo P; Romano F
    Int J Fertil; 1969; 14(2):180-7. PubMed ID: 4181574
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experiences with Ovosiston in a new dosage form].
    Zwahr C
    Dtsch Gesundheitsw; 1970 Apr; 25(14):635-9. PubMed ID: 4098545
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of ovulation by estrogens.
    Gual C; Becerra C; Rice-Wray E; Goldzieher JW
    Am J Obstet Gynecol; 1967 Feb; 97(4):443-7. PubMed ID: 4163201
    [No Abstract]   [Full Text] [Related]  

  • 14. [Indications for the treatment with sequence preparations].
    Breckwoldt M; Bettendorf G
    Zentralbl Gynakol; 1969 Aug; 91(35):1147-50. PubMed ID: 4189508
    [No Abstract]   [Full Text] [Related]  

  • 15. [Inhibitors of human ovulation. General principles and accumulated experiences with sequential therapy based on mestranol and chlormadinone acetate].
    Zorrilla E
    Prensa Med Mex; 1968; 33(11):453-64. PubMed ID: 4105432
    [No Abstract]   [Full Text] [Related]  

  • 16. [Two-stage therapy as a method of hormonal contraception in comparison with compound preparations].
    Rothe K
    Z Gesamte Hyg; 1970 Apr; 16(4):289-90. PubMed ID: 4108397
    [No Abstract]   [Full Text] [Related]  

  • 17. ["1st experiences with Ovosiston in a new dosage--a comparative study of oral contraception with 'old' and 'new' Ovosiston". "Experiences with Ovosiston in contraception. II. " Reply to the viewpoint of D. Kühne].
    Zwahr C
    Dtsch Gesundheitsw; 1970 Nov; 25(47):2247-50. PubMed ID: 4099776
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experiences with Ovosiston in marital and sexual counseling in a district hospital in the period Jan. 1, 1967-Dec. 31, 1968].
    Keil G
    Z Arztl Fortbild (Jena); 1970 May; 64(10):500-1. PubMed ID: 4106558
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of an oral contraceptive Femigen-Polfa by epileptic women].
    Rościszewska D
    Neurol Neurochir Pol; 1973; 7(5):715-7. PubMed ID: 4128492
    [No Abstract]   [Full Text] [Related]  

  • 20. [Protein metabolism in women using Femigen Polfa as peroral contraceptives].
    Firek A; Pisarek-Miedzińska D; Wójcicka J; Korc R
    Ginekol Pol; 1973 Nov; 44(11):1303-8. PubMed ID: 4129073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.